Kyoto University

Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . EUSA, BeiGene Ink $160m Alli

Third quarter biopharmaceutical start-up financings fell 23% from the second quarter, but large individual company financings continue to stand out, including Century Therapeutics with a $250m serie

As Hatteras Venture Partners gets ready to fund a new slate of early-stage biopharmaceutical, medical device, digital health and diagnostic companies, General Partner Clay Thorp told Scrip the ventu